Controversy surrounded Him & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

People who have struggled with their weight have found relief with a new drug. But then their weight loss ground to a halt. A ...

Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...

Ozempic and other semaglutide medications work by mimicking GLP-1—a natural hormone produced in the intestines that regulates ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

In response to complaints made publicly by the Partnership for Safe Medicine and the Obesity Society, Hims & Hers provided Yahoo Life with the following statement: This is a clear attempt by industry ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

In response to complaints made publicly by the Partnership for Safe Medicines and the Obesity Society (TOS), Hims & Hers provided Yahoo Life with the following statement: This is a clear attempt by ...